Global Neuropathic Pain Market
市场规模（十亿美元）
CAGR :
% 
USD
6.39 Billion
USD
12.93 Billion
2024
2032
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 6.39 Billion |
 Market Size (Forecast Year) |
USD 12.93 Billion |
 CAGR |
% |
| Major Markets Players |
|
全球神經性疼痛市場細分，按類型（脊髓刺激（SCS）設備、週邊神經刺激、經皮神經電刺激（TENS）設備、局部神經病變、自動神經病變和近端神經病變）、產品類型（可充電和不可充電）、程序（侵入性和非侵入性）、技術（經皮神經電刺激、經顱磁病刺激和呼吸電刺激）、方式（非處方藥和非處方藥）經病變、幻肢神經病變、三叉神經痛、帶狀皰疹後神經痛（PHN）、創傷後神經病變、足痛和尾骨痛）、適應症（椎管狹窄、化療引起的周邊神經病變、糖尿病神經病變等）、診斷（影像學、血液檢查和身體檢查）、治療（藥物和多模式治療）、最終用戶（醫院、診所、家庭醫療保健、 門診手術中心、研究機構等）、分銷渠道（直接投標、第三方分銷商等）——行業趨勢及預測（至2032 年）
神經性疼痛市場規模
- 2024 年全球神經性疼痛市場規模為63.9 億美元 ，預計 到 2032 年將達到 129.3 億美元，預測期內 複合年增長率為 9.20%。
- 市場成長主要源自於糖尿病、癌症和多發性硬化症等慢性疾病的盛行率上升，這些疾病是神經性疼痛的主要潛在原因。全球老年人口的不斷增長進一步加劇了這一趨勢，因為老年人更容易受到神經損傷及相關併發症的影響。
- 此外，對有效且持久治療方案的需求日益增長，推動了藥物創新以及針對性神經性疼痛療法的開發，包括抗憂鬱藥物、抗驚厥藥物和外用藥物。這些因素共同加速了神經性疼痛解決方案的普及，顯著促進了該行業的成長。
神經性疼痛市場分析
- 神經性疼痛治療包括藥物和非藥物療法，因其在治療複雜的神經相關疾病、改善患者生活品質和降低長期醫療成本方面的功效，已成為醫院和門診慢性疼痛管理中越來越重要的組成部分
- 神經性疼痛治療需求的不斷增長，主要源於糖尿病、癌症和神經系統疾病的日益流行，以及全球人口老化。此外，認知度的提升和診斷能力的提高，也促進了治療率的提高和早期介入的發展。
- 北美在神經性疼痛市場佔據主導地位，2024 年其收入份額最大，為 49.33%，這得益於完善的醫療基礎設施、患者和從業人員的高度認知以及主要製藥公司的強大影響力
- 預計亞太地區將成為預測期內神經性疼痛市場成長最快的地區，預計複合年增長率為 8.4%，這得益於醫療保健投資的增加、患者獲得疼痛管理療法的機會的擴大以及印度、中國和日本等國家糖尿病和中風等慢性病發病率的上升
- 脊髓刺激 (SCS) 設備領域在神經性疼痛市場中佔據主導地位，2024 年的市場份額為 31.4%，這得益於其在治療對傳統療法無反應的慢性疼痛方面的有效性、長期成本效益以及微創神經調節療法的日益普及
報告範圍和神經性疼痛市場細分
|
屬性 |
神經性疼痛關鍵市場洞察 |
|
涵蓋的領域 |
|
|
覆蓋國家 |
北美洲
歐洲
亞太
中東和非洲
南美洲
|
|
主要市場參與者 |
|
|
市場機會 |
|
|
加值資料資訊集 |
除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察之外，Data Bridge Market Research 策劃的市場報告還包括深入的專家分析、定價分析、品牌份額分析、消費者調查、人口統計分析、供應鏈分析、價值鏈分析、原材料/消耗品概述、供應商選擇標準、PESTLE 分析、波特分析和監管框架。 |
神經性疼痛市場趨勢
“對智慧化和整合治療解決方案的需求日益增長”
- 全球神經性疼痛市場的一個重要且正在加速發展的趨勢是智慧治療系統與個人化治療方案的整合。數位健康平台和互聯醫療設備的進步正在增強患者管理，並優化疼痛緩解策略。
- 例如，穿戴式科技和連網裝置越來越多地用於監測疼痛程度和藥物依從性，使醫療保健提供者能夠即時調整治療方案，從而在神經性疼痛管理中獲得更好的結果
- 此外，數據分析工具正被用於追蹤患者對特定藥物的反應，識別誘因並改善治療方案。一些數位健康平台提供預測模型，根據行為和生理輸入預測疼痛發作。
- 這些工具與電子健康記錄 (EHR) 的無縫連接，使臨床醫生能夠更全面地管理神經性疼痛。這種互通性不僅減少了臨床錯誤，還簡化了治療優化和追蹤安排。
- NeuroMetrix 等公司正引領該領域的創新，其解決方案包括 Quell，這是一種用於治療慢性疼痛的可穿戴設備，利用神經刺激和數位追蹤來增強緩解並實現個人化治療
- 隨著患者期望越來越個人化、互聯互通和便捷的護理，醫院和家庭護理環境對先進的綜合神經性疼痛管理解決方案的需求正在上升
神經性疼痛市場動態
司機
“慢性病盛行率不斷上升，對有效疼痛管理解決方案的需求也日益增長”
- 糖尿病、癌症和多發性硬化症等慢性疾病（神經性疼痛的主要誘因）的盛行率不斷上升，近年來極大地推動了對有針對性、有效的疼痛管理療法的需求
- 例如，2024 年 3 月，諾華公司擴大了其研究化合物 LX9211 的臨床開發，該化合物旨在治療糖尿病週邊神經性疼痛，突顯了公司為滿足市場日益增長的治療需求而進行的持續研發投資
- 隨著全球人口老化和慢性病負擔的不斷加重，醫療保健系統越來越重視透過全面的疼痛管理策略來改善生活品質。這導致神經性疼痛治療的採用率激增，包括抗驚厥藥物、抗憂鬱藥物以及鈉通道阻斷劑和外用藥物等新型療法。
- 此外，個人化醫療的轉變以及使用生物標記為個別患者量身定制治療方案，進一步提高了神經性疼痛治療的療效，改善了治療結果並提高了患者滿意度
- 隨著先進治療方案的日益普及，以及醫療服務提供者和患者意識的不斷提升，預計將繼續推動全球神經性疼痛市場的顯著成長。製藥巨頭正在大力投資臨床試驗和產品創新，以滿足尚未滿足的需求，尤其是在非鴉片類藥物止痛領域。
克制/挑戰
“當前療法的副作用以及低收入地區治療機會的有限性”
- 儘管神經性疼痛市場具有成長潛力，但其面臨與現有療法副作用相關的顯著挑戰。許多常用藥物，例如三環抗憂鬱劑和加巴噴丁類藥物，已知會引起嗜睡、頭暈和胃腸道不適，導致患者依從性較差。
- 例如，在多項臨床試驗中，加巴噴丁和普瑞巴林顯示出治療神經性疼痛的有效性，但由於耐受性問題，也導致了較高的退出率。這催生了對更新、更安全的替代品的需求，但臨床研發進展緩慢，難以帶來突破性的創新。
- 此外，由於藥品價格高、診斷能力不足以及缺乏專門的疼痛診所，許多中低收入國家獲得神經性疼痛治療的機會仍然有限
- 成本敏感型市場往往無法充分服務，患者依賴非處方止痛藥，而這些止痛藥對神經相關疼痛的緩解作用微乎其微
- 透過擴大可及性項目、開發具有成本效益的仿製藥以及建立全球衛生夥伴關係來彌合這些差距，對於確保公平獲得醫療服務至關重要。此外，還需要進行教育活動並制定臨床指南，以支持醫生更有效地診斷和管理神經性疼痛，尤其是在基層醫療機構。
神經性疼痛市場範圍
市場根據類型、產品類型、程序、技術、方式、購買方式、疼痛類型、適應症、診斷、治療、最終用戶和分銷管道進行細分。
• 依類型
根據類型，神經性疼痛市場細分為脊髓刺激 (SCS) 設備、週邊神經刺激 (EPN)、經皮神經電刺激 (TENS) 設備、局部神經病變、自發性神經病變和近端神經病變。脊髓刺激 (SCS) 設備細分市場佔據市場主導地位，2024 年收入份額最高，達到 31.4%，這得益於 SCS 在緩解慢性神經性疼痛方面的高效性，尤其是在藥物治療無效的病例中。 FDA 批准數量的增加以及微型植入式設備等技術進步也是推動因素。
由於非侵入性疼痛緩解方法的日益普及以及在家庭醫療保健環境中的使用日益增多，經皮電神經刺激 (TENS) 設備領域預計將在 2025 年至 2032 年間見證最快的複合年增長率 8.9%。
• 依產品類型
根據產品類型，神經性疼痛市場分為可充電和不可充電設備。由於設備壽命更長且長期使用具有成本效益，可充電設備在2024年佔據最大份額，達到58.3%。
預計從 2025 年到 2032 年，非充電電池領域的複合年增長率將達到 6.7%，尤其是在短期治療用途和偏好低維護解決方案的老年患者中。
• 依程序
根據治療方式，神經性疼痛市場可分為侵入性和非侵入性治療。非侵入性治療在2024年佔據主導地位，市場份額達61.2%，因為越來越多的患者青睞疼痛程度較低且恢復期較短的治療方法。
由於精密手術技術的進步和神經刺激植入物的接受度不斷提高，預計 2025 年至 2032 年侵入性領域將以 7.5% 的複合年增長率增長。
• 依技術
根據技術，神經性疼痛市場細分為經皮神經電刺激 (TENS)、經顱磁刺激 (TMS) 和呼吸電刺激。經皮神經電刺激 (TENS) 技術在 2024 年佔據 45.8% 的市場份額，領先市場，因其價格實惠且易於整合到家用設備中而廣泛應用。
由於越來越多的臨床試驗證明經顱磁刺激 (TMS) 對神經相關憂鬱症和神經病變的療效，預計 2025 年至 2032 年間，經顱磁刺激 (TMS) 的複合年增長率將達到 9.4%。
• 依方式
根據治療方式，神經性疼痛市場可分為固定式和可攜式。便攜式市場佔據主導地位，2024 年市場份額最大，達到 66.9%，這得益於患者對家用設備的日益偏好以及醫療服務向分散化轉變。
預計固定式醫療設備市場在 2025 年至 2032 年期間的複合年增長率為 6.2%，由於其治療能力更強、應用環境更廣泛，在醫院和專科診所中仍將佔據重要地位。
• 依購買方式
根據購買方式，神經性疼痛市場可分為非處方設備和處方藥。由於監管規定及其在專科治療中的應用，處方藥在2024年佔據了59.1%的主要市場份額。
受消費者健康意識的提高和可負擔得起的疼痛管理工具的普及的推動，非處方設備預計將在 2025 年至 2032 年間以 10.1% 的最快複合年增長率增長。
• 依疼痛類型
根據疼痛類型，神經性疼痛市場細分為週邊神經病變、卡壓性神經病變、幻肢神經病變、三叉神經痛、帶狀皰疹後神經痛 (PHN)、創傷後神經病變、足部疼痛和尾骨痛。週邊神經病變市場在 2024 年佔據主導地位，市場佔有率達 39.4%，這主要是因為其盛行率較高，尤其是在糖尿病患者中。
由於老齡人口中帶狀皰疹感染發病率的上升，預計帶狀皰疹後神經痛 (PHN) 領域從 2025 年到 2032 年的複合年增長率將達到 8.6%。
• 按適應症
根據適應症，神經性疼痛市場細分為椎管狹窄症、化療引起的周邊神經病變 (CIPN)、糖尿病神經病變等。受全球糖尿病盛行率上升的推動，糖尿病性神經病變在 2024 年佔據了最大的收入份額，達到 42.7%。
由於尋求長期緩解疼痛的癌症倖存者數量不斷增加，化療引起的周邊神經病變 (CIPN) 預計將經歷最快的增長，2025 年至 2032 年期間的複合年增長率為 9.2%。
• 根據診斷
根據診斷，神經性疼痛市場細分為影像學檢查、血液檢查和身體檢查。影像學檢查領域在2024年佔據48.5%的市場份額，佔據市場主導地位，且MRI和CT掃描在檢測神經損傷方面的應用日益廣泛。
由於體檢在初級保健中的廣泛應用，預計 2025 年至 2032 年體檢領域的複合年增長率將達到 6.9%。
• 依治療
根據治療方案，神經性疼痛市場可細分為藥物治療和多模式治療。 2024年，藥物治療佔據市場主導地位，市佔率達64.8%，這得益於鎮痛藥、抗驚厥藥和抗憂鬱藥的廣泛普及。
隨著醫療保健提供者越來越多地推薦結合物理、藥物和認知治療的綜合方法，多模式治療預計將在 2025 年至 2032 年間以 10.5% 的最快複合年增長率增長。
• 按最終用戶
根據最終用戶，神經性疼痛市場可細分為醫院、診所、家庭醫療保健、門診手術中心、研究機構等。由於醫院擁有專業的護理和先進的治療設備，其市佔率在2024年最高，達49.34%。
由於越來越多的慢性疼痛患者傾向於家庭治療，預計家庭醫療保健領域在 2025 年至 2032 年間將以 9.8% 的複合年增長率最快增長。
• 按分銷管道
根據分銷管道，神經性疼痛市場可細分為直接招標、第三方分銷商和其他。直接招標市場佔據主導地位，2024 年市佔率達 52.4%，主要受醫院和公共衛生系統的大量採購所驅動。
由於新興經濟體中私人醫療設施和設備普及率的不斷擴大，第三方經銷商領域在 2025 年至 2032 年期間的複合年增長率可能達到 8.7%。
神經性疼痛市場區域分析
- 北美在神經性疼痛市場佔據主導地位，2024 年的收入份額最大，為 49.33%，這主要得益於糖尿病和癌症等慢性疾病的盛行率上升，而這些慢性疾病是神經性疼痛的主要潛在原因
- 該地區的患者越來越多地尋求先進的疼痛管理療法，包括神經刺激設備和多模式治療，並得到強大的醫療基礎設施和廣泛可報銷療法的支持
- 強勁的研發投入、對早期診斷和治療的高度認知度以及主要市場參與者提供技術先進的設備，進一步支持了市場的成長，使北美成為神經性疼痛創新和治療應用的中心
美國神經性疼痛市場洞察
美國神經性疼痛市場在2024年佔了最大的收入份額。這種主導地位得益於神經調節設備和多模式治療方案等先進療法的廣泛應用。便捷的診斷技術、高昂的醫療支出以及強勁的研發投入支撐了這一成長。
歐洲神經性疼痛市場洞察
預計歐洲神經性疼痛市場在2025-2032年的預測期內將以顯著的複合年增長率擴張。這主要得益於嚴格的安全法規以及對家庭和辦公室安全日益增長的需求。由於糖尿病和癌症相關神經病變發病率的上升，以及經皮神經電刺激（TENS）和經顱磁刺激（TMS）等非侵入性治療的廣泛應用，預計該地區將以健康的複合年增長率增長。
亞太神經性疼痛市場洞察
預計 2025 年至 2032 年間，亞太地區神經性疼痛市場將以 8.4% 的最快複合年增長率成長。成長的動力來自中國和印度等國家不斷擴大的醫療保健基礎設施、日益增長的慢性病盛行率以及採用具有成本效益的治療方法。
日本神經性疼痛市場洞察
預計 2025 年至 2032 年間，日本神經性疼痛市場將以 6.2% 的複合年增長率成長。這一增長得益於其人口老化、先進的醫療保健系統以及可穿戴和可植入疼痛管理設備的普及率提高。
中國神經性疼痛市場洞察
2024 年，中國神經性疼痛市場佔了最大的市場收入份額。這一增長得益於強勁的國內製造業、政府投資和高慢性病負擔。
神經性疼痛市場份額
神經性疼痛產業主要由知名公司主導，包括：
- NEVRO CORP.（美國）
- 禮來（美國）
- 安斯泰來製藥公司（日本）
- Biogen（美國）
- Cirtec（美國）
- Integer Holdings Corporation（美國）
- B. Braun SE（德國）
- 美敦力（愛爾蘭）
- 雅培（美國）
- 波士頓科學公司（美國）
- 歐姆龍健康護理有限公司（日本）
- electroCore, Inc.（美國）
- Polar Medical Ltd（英國）
- SunMED Medical（美國）
- NeuroMetrix, Inc.（美國）
全球神經性疼痛市場的最新發展
- 2025年4月，維吉尼亞理工大學的研究人員證明，非侵入性經脊髓聚焦超音波 (tsFUS) 可以顯著降低脊髓損傷模型的疼痛敏感性和神經發炎。這項為期3天、每次3分鐘的短療程，無需藥物或手術，即可帶來持續數週的緩解，這為非藥物疼痛管理指明了方向。
- 2025年3月，《柳葉刀神經病學》雜誌發布了最新的全球神經性疼痛治療臨床指南，重申α2δ配體（普瑞巴林、加巴噴丁）、SNRI（度洛西汀）和TCA（阿米替林）作為一線治療方案。該指南也強調了阿片類藥物療效有限以及多模式治療策略的必要性。
- 2025年1月，FDA批准了Vertex Pharmaceuticals公司生產的Suzetrigine（Journavx），這是20多年來首個用於治療急性疼痛的非鴉片類止痛藥。 Suzetrigine主要針對術後急性疼痛，目前正在進行進一步研究，以評估其在治療慢性神經病變方面的潛力。
- 2025年2月，海思科藥業集團在美國和歐洲擴大了其下一代GABA類似物Crisugabalin (HSK16149)的臨床開發，該藥物於2024年在中國獲得監管部門批准，用於治療糖尿病性神經病變和帶狀皰疹後神經痛
- 2025年3月，新南威爾斯大學雪梨分校的研究人員推出了一款名為「PainWaive」的數位神經回饋應用程序，該應用程式與一款讀腦耳機配套使用，旨在幫助患者自我調節與慢性疼痛相關的大腦活動。早期研究表明，患者的生活品質和疼痛感知有所改善，這預示著非藥物居家療法的未來。
- 2025 年 6 月，即將在柏林舉行的第九屆國際神經性疼痛大會 (NeuPSIG 2025) 預計將展示神經調節、基於人工智慧的診斷和非阿片類藥物治療方面的重大進展，從而加強向個性化和技術驅動的疼痛管理的轉變
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
- INTRODUCTION
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW OF GLOBAL NEUROPATHIC PAIN MARKET
- LIMITATIONS
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- GEOGRAPHICAL SCOPE
- YEARS CONSIDERED FOR THE STUDY
- CURRENCY AND PRICING
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- TYPE LIFELINE CURVE
- PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
- DBMR MARKET POSITION GRID
- VENDOR SHARE ANALYSIS
- MARKET TYPE OF MANUFACTURER COVERAGE GRID
- SECONDARY SOURCES
- ASSUMPTIONS
- EXECUTIVE SUMMARY
- PREMIUM INSIGHT
- REGULATION
- REGULATORY GUIDELINES AS PER USFDA
- REGULATORY GUIDELINES AS PER EUROPEAN UNION
- MARKET OVERVIEW
- DRIVERS
- GROWING PREVALENCE OF CHRONIC PAIN AND NEUROPATHIC CONDITION
- INCREASING CASES OF DIABETIC NEUROPATHY
- INCREASING R&D EXPENDITURE
- ADVANCEMENT IN NEW NEUROMODULATION TECHNOLOGY
- PENETRATION OF THE NEW MARKET PLAYERS
- RESTRAINTS
- HIGH COST OF THE MEDICAL DEVICES
- LOW AWARENESS FOR NEUROPATHIC PAIN DEVICES
- UNFAVORABLE GOVERNMENT POLICIES
- LIMITATION OF NEUROPATHIC MEDICAL DEVICES
- OPPORTUNITIES
- HIGH RISK OF NEUROPATHIC PAIN WITH AGEING
- GOVERNMENT INITIATIVES FOR NEUROPATHIC PAIN
- APPROPRIATE REIMBURSEMENT POLICY FOR THE MEDICAL DEVICES
- CHALLENGES
- DEARTH OF SKILLED PROFESSIONALS
- USE OF TRADITIONAL THERAPY IN EMERGING ECONOMIES
- IMPACT OF COVID-19 ON THE GLOBAL NEUROPATHIC PAIN MARKET
- OVERVIEW
- IMPACT ON PRICE
- IMPACT ON SUPPLY
- STRATEGIC DECISIONS BY MANUFACTURERS
- CONCLUSION-
- GLOBAL NEUROPATHIC PAIN MARKET, BY TYPE
- OVERVIEW
- SPINAL CORD STIMULATION (SCS) DEVICES
- RECHARGEABLE IMPLANTABLE PULSE GENERATOR
- RADIOFREQUENCY STIMULATOR
- CONVENTIONAL IMPLANTABLE PULSE GENERATOR/ IPG
- EXTERNAL PERIPHERAL NERVE STIMULATION
- DEEP BRAIN STIMULATORS (DBS)
- DUAL-CHANNEL DEEP BRAIN STIMULATOR
- SINGLE-CHANNEL DEEP BRAIN STIMULATOR
- TRANSCRANIAL MAGNETIC STIMULATORS (TMS)
- VAGUS NERVE STIMULATORS (VNS)
- SACRAL NERVE STIMULATORS (SNS)
- TRANSCUTANEOUS ELECTRIC NERVE STIMULATION (TENS) DEVICES
- CONVENTIONAL TENS (LOW-INTENSITY, HIGH-FREQUENCY)
- ACUPUNCTURE-LIKE TENS (HIGH-INTENSITY, LOW-FREQUENCY)
- INTENSE TENS (HIGH-INTENSITY, HIGH-FREQUENCY)
- GLOBAL NEUROPATHIC PAIN MARKET, BY PRODUCT TYPE
- OVERVIEW
- RECHARGEABLE
- NON- RECHARGEABLE
- GLOBAL NEUROPATHIC PAIN MARKET, BY PROCEDURE
- OVERVIEW
- NON-INVASIVE
- INVASIVE
- GLOBAL NEUROPATHIC PAIN MARKET, BY TECHNOLOGY
- OVERVIEW
- TRANSCUTANEOUS ELECTRIC NERVE STIMULATION
- TRANSCRANIAL MAGNETIC STIMULATION
- RESPIRATORY ELECTRICAL STIMULATION
- GLOBAL NEUROPATHIC PAIN MARKET, BY MODALITY
- OVERVIEW
- PORTABLE
- RECHARGEABLE
- NON- RECHARGEABLE
- STATIONARY
- RECHARGEABLE
- NON- RECHARGEABLE
- GLOBAL NEUROPATHIC PAIN MARKET, BY MODE OF PURCHASE
- OVERVIEW
- PRESCRIPTION-BASED DEVICES
- OVER-THE-COUNTER DEVICES
- GLOBAL NEUROPATHIC PAIN MARKET, BY PAIN TYPE
- OVERVIEW
- PERIPHERAL NEUROPATHY
- PHANTOM LIMB PAIN
- POST HERPETIC NEURALGIA (PHN)
- POST TRAUMATIC NEUROPATHY
- ENTRAPMENT NEUROPATHY
- FOOT PAIN
- TRIGEMINAL NEURALGIA
- COCCYDYNIA
- OTHERS
- GLOBAL NEUROPATHIC PAIN MARKET, BY INDICATION
- OVERVIEW
- SPINAL STENOSIS
- SPINAL CORD STIMULATION (SCS) DEVICES
- TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) DEVICES
- EXTERNAL PERIPHERAL NERVE STIMULATION
- DIABETIC NEUROPATHY
- SPINAL CORD STIMULATION (SCS) DEVICES
- TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) DEVICES
- EXTERNAL PERIPHERAL NERVE STIMULATION
- CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
- SPINAL CORD STIMULATION (SCS) DEVICES
- TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) DEVICES
- EXTERNAL PERIPHERAL NERVE STIMULATION
- OTHERS
- GLOBAL NEUROPATHIC PAIN MARKET, BY END USER
- OVERVIEW
- CLINICS
- HOSPITALS
- ACUTE CARE HOSPITALS
- LONG-TERM CARE HOSPITALS
- NURSING FACILITIES
- REHABILITATION CENTERS
- HOME HEALTHCARE
- AMBULATORY SURGICAL CENTERS
- OTHERS
- GLOBAL NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL
- OVERVIEW
- DIRECT TENDERS
- THIRD PARTY DISTRIBUTION
- OTHERS
- GLOBAL NEUROPATHIC PAIN MARKET BY GEOGRAPHY
- OVERVIEW
- NORTH-AMERICA
- U.S.
- CANADA
- MEXICO
- EUROPE
- GERMANY
- FRANCE
- U.K.
- ITALY
- RUSSIA
- SPAIN
- NETHERLANDS
- TURKEY
- SWITZERLAND
- REST OF EUROPE
- ASIA-PACIFIC
- CHINA
- JAPAN
- AUSTRALIA
- INDIA
- SOUTH KOREA
- SINGAPORE
- MALAYSIA
- THAILAND
- INDONESIA
- PHILIPPINES
- REST OF ASIA-PACIFIC
- MIDDLE EAST AND AFRICA
- SOUTH AFRICA
- SAUDI ARABIA
- UAE
- ISRAEL
- EGYPT
- REST OF MIDDLE EAST & AFRICA
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- REST OF SOUTH AMERICA
- GLOBAL NEUROPATHIC PAIN MARKET: COMPANY LANDSCAPE
- COMPANY SHARE ANALYSIS: GLOBAL
- COMPANY SHARE ANALYSIS: NORTH AMERICA
- COMPANY SHARE ANALYSIS: EUROPE
- COMPANY SHARE ANALYSIS: ASIA-PACIFIC
- SWOT ANALYSIS
- COMPANY PROFILE
- MEDTRONIC
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- COMPANY SHARE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- BOSTON SCIENTIFIC CORPORATION
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- COMPANY SHARE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- ABBOTT
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- COMPANY SHARE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- NERVO CORP.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- COMPANY SHARE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- OMRON HEALTHCARE, INC.
- COMPANY SNAPSHOT
- COMPANY SHARE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- INTERGER HOLDINGS CORPORATION
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- AVNS
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- B.BRAUN MELSUNGEN AG
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- CIRTEC
- 428
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- ELECTROCORE, INC.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- NEUROMETRIX, INC.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- POLAR MEDICAL
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- SPR THERAPEUTICS
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- STIMWAVE LLC.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- SUNMED
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- QUESTIONNAIRE
- RELATED REPORTS
表格列表
TABLE 1 Global Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 2 Global Spinal Cord Stimulation (SCS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 3 Global Spinal Cord Stimulation (SCS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 4 Global External Peripheral Nerve Stimulationin Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 5 Global External Peripheral Nerve Stimulationin Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 6 Global Deep Brain Stimulators (DBS) in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 7 Global Transcutaneous Electrical Nerve Stimulation (TENS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 8 Global Transcutaneous Electrical Nerve Stimulation (TENS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 9 Global Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)
TABLE 10 Global Rechargeable in Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)
TABLE 11 Global Non-Rechargeable Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)
TABLE 12 Global Neuropathic Pain Device Market, By Procedure, 2019-2028 (USD Million)
TABLE 13 Global Non-Invasive Invasive in Neuropathic Pain Device Market, By Procedure, 2019-2028 (USD Million)
TABLE 14 Global Invasive in Neuroendocrine Tumors Market, By Classification 2019-2027 (USD Million)
TABLE 15 Global Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)
TABLE 16 Global Transcutaneous Electrical Nerve Stimulation Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)
TABLE 17 Global Transcranial Magnetic Stimulation Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)
TABLE 18 Global Respiratory Electrical Stimulation Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)
TABLE 19 Global Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 20 Global Portable Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 21 Global Portable in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 22 Global Stationary Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 23 Global Stationary Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 24 Global Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)
TABLE 25 Global Prescription-Based Devices Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)
TABLE 26 Global Over-The-Counter Devices Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)
TABLE 27 Global Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 28 Global Peripheral Neuropathy Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 29 Global Phantom Limb Pain Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 30 Global Post Herpetic Neuralgia (PHN) Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 31 Global Post Traumatic NeuropathyNeuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 32 Global Entrapment Neuropathy Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 33 Global Foot Pain Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 34 Global Trigeminal Neuralgia Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 35 Global Coccydynia Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 36 Global Others Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 37 Global Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 38 Global Spinal Stenosis Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 39 Global Spinal Stenosis in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 40 Global Diabetic Neuropathy Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 41 Global Diabetic Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 42 Global Chemotherapy-Induced Peripheral Neuropathy Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 43 Global Chemotherapy-Induced Peripheral Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 44 Global Others Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 45 Global Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 46 Global Clinics Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 47 Global Hospitals Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 48 Global Hospitals in Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 49 Global Home Healthcare Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 50 Global Ambulatory Surgical Centers Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 51 Global Others Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 52 Global Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 53 Global Direct Tenders Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 54 Global Third Party Distribution Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 55 Global Others Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 56 GLOBAL neuropathic Pain MARKET, BY REGION , 2021-2028 (USD MILLION)
TABLE 57 North-america NEUROPATHIC PAIN MARKET, By Region, 2019-2028 (USD Million)
TABLE 58 NORTH-AMERICA NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 59 NORTH-AMERICA Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 60 NORTH-AMERICA External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 61 NORTH-AMERICA Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 62 NORTH-AMERICA Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 63 NORTH-AMERICA NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 64 NORTH-AMERICA NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 65 NORTH-AMERICA NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 66 NORTH-AMERICA NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 67 NORTH-AMERICA Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 68 NORTH-AMERICA portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 69 NORTH-AMERICA NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 70 NORTH-AMERICA NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 71 NORTH-AMERICA NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 72 NORTH-AMERICA SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 73 NORTH-AMERICA Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 74 NORTH-AMERICA Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 75 NORTH-AMERICA NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 76 NORTH-AMERICA hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 77 NORTH-AMERICA NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 78 U.S. NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 79 U.S. Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 80 U.S. External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 81 NORTH-AMERICA Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 82 U.S. Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 83 U.S. NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 84 U.S. NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 85 U.S. NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 86 U.S. NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 87 U.S. Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 88 U.S. portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 89 U.S. NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 90 U.S. NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 91 U.S. NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 92 U.S. SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 93 U.S. Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 94 U.S. Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 95 U.S. NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 96 U.S. hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 97 U.S. NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 98 canada NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 99 canada Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 100 canada External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 101 canada Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 102 canada Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 103 canada NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 104 canada NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 105 canada NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 106 canada NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 107 canada Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 108 canada portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 109 canada NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 110 canada NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 111 canada NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 112 canada SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 113 canada Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 114 canada Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 115 canada NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 116 canada hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 117 canada NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 118 mexico NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 119 mexico Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 120 mexico External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 121 mexico Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 122 mexico Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 123 mexico NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 124 mexico NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 125 mexico NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 126 mexico NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 127 mexico Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 128 mexico portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 129 mexico NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 130 mexico NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 131 mexico NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 132 mexico SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 133 mexico Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 134 mexico Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 135 mexico NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 136 mexico hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 137 mexico NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 138 Europe NEUROPATHIC PAIN MARKET, By Region, 2019-2028 (USD Million)
TABLE 139 EUROPE NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 140 EUROPE Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 141 EUROPE External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 142 EUROPE Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 143 EUROPE Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 144 EUROPE NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 145 EUROPE NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 146 EUROPE NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 147 EUROPE NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 148 EUROPE Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 149 EUROPE portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 150 EUROPE NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 151 EUROPE NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 152 EUROPE NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 153 EUROPE SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 154 EUROPE Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 155 EUROPE Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 156 EUROPE NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 157 EUROPE hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 158 EUROPE NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 159 GERMANY NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 160 GERMANY Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 161 GERMANY External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 162 germany Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 163 GERMANY Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 164 GERMANY NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 165 GERMANY NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 166 GERMANY NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 167 GERMANY NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 168 GERMANY Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 169 GERMANY portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 170 GERMANY NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 171 GERMANY NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 172 GERMANY NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 173 GERMANY SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 174 GERMANY Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 175 GERMANY Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 176 GERMANY NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 177 GERMANY hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 178 GERMANY NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 179 france NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 180 france Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 181 france External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 182 france Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 183 france Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 184 france NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 185 france NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 186 france NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 187 france NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 188 france Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 189 france portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 190 france NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 191 france NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 192 france NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 193 france SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 194 france Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 195 france Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 196 france NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 197 france hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 198 france NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 199 U.K. NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 200 U.K. Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 201 U.K. External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 202 U.K. Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 203 U.K. Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 204 U.K. NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 205 U.K. NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 206 U.K. NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 207 U.K. NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 208 U.K. Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 209 U.K. portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 210 U.K. NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 211 U.K. NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 212 U.K. NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 213 U.K. SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 214 U.K. Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 215 U.K. Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 216 U.K. NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 217 U.K. hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 218 U.K. NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 219 italy NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 220 italy Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 221 italy External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 222 italy Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 223 italy Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 224 italy NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 225 italy NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 226 italy NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 227 italy NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 228 italy Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 229 italy portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 230 italy NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 231 italy NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 232 italy NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 233 italy SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 234 italy Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 235 italy Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 236 italy NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 237 italy hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 238 italy NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 239 russia NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 240 russia Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 241 russia External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 242 russia Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 243 russia Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 244 russia NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 245 russia NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 246 russia NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 247 russia NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 248 russia Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 249 russia portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 250 russia NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 251 russia NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 252 russia NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 253 russia SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 254 russia Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 255 russia Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 256 russia NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 257 russia hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 258 russia NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 259 spain NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 260 spain Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 261 spain External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 262 spain Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 263 spain Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 264 spain NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 265 spain NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 266 spain NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 267 spain NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 268 spain Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 269 spain portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 270 spain NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 271 spain NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 272 spain NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 273 spain SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 274 spain Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 275 spain Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 276 russia NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 277 spain hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 278 spain NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 279 Netherlands NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 280 Netherlands Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 281 Netherlands External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 282 Netherlands Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 283 Netherlands Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 284 Netherlands NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 285 Netherlands NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 286 Netherlands NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 287 Netherlands NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 288 Netherlands Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 289 Netherlands portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 290 Netherlands NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 291 Netherlands NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 292 Netherlands NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 293 Netherlands SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 294 Netherlands Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 295 Netherlands Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 296 Netherlands NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 297 Netherlands hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 298 Netherlands NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 299 turkey NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 300 turkey Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 301 turkey External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 302 turkey Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 303 turkey Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 304 turkey NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 305 turkey NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 306 turkey NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 307 turkey NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 308 turkey Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 309 turkey portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 310 turkey NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 311 turkey NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 312 turkey NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 313 turkey SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 314 turkey Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 315 turkey Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 316 turkey NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 317 turkey hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 318 turkey NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 319 Switzerland NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 320 Switzerland Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 321 Switzerland External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 322 Switzerland Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 323 Switzerland Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 324 Switzerland NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 325 Switzerland NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 326 Switzerland NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 327 Switzerland NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 328 Switzerland Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 329 Switzerland portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 330 Switzerland NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 331 Switzerland NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 332 Switzerland NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 333 Switzerland SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 334 Switzerland Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 335 Switzerland Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 336 Switzerland NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 337 Switzerland hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 338 Switzerland NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 339 Rest of Europe NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 340 Asia-Pacific NEUROPATHIC PAIN MARKET, By Region, 2019-2028 (USD Million)
TABLE 341 ASIA-PACIFIC NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 342 ASIA-PACIFIC Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 343 ASIA-PACIFIC External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 344 ASIA-PACIFIC Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 345 ASIA-PACIFIC Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 346 ASIA-PACIFIC NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 347 ASIA-PACIFIC NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 348 ASIA-PACIFIC NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 349 ASIA-PACIFIC NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 350 ASIA-PACIFIC Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 351 ASIA-PACIFIC portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 352 ASIA-PACIFIC NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 353 ASIA-PACIFIC NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 354 ASIA-PACIFIC NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 355 ASIA-PACIFIC SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 356 ASIA-PACIFIC Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 357 ASIA-PACIFIC Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 358 ASIA-PACIFIC NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 359 ASIA-PACIFIC hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 360 ASIA-PACIFIC NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 361 china NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 362 china Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 363 china External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 364 china Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 365 china Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 366 china NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 367 china NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 368 china NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 369 china NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 370 china Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 371 china portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 372 china NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 373 china NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 374 china NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 375 china SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 376 china Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 377 china Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 378 china NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 379 china hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 380 china NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 381 japan NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 382 japan Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 383 japan External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 384 japan Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 385 japan Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 386 japan NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 387 japan NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 388 japan NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 389 japan NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 390 japan Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 391 japan portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 392 japan NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 393 japan NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 394 japan NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 395 japan SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 396 japan Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 397 japan Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 398 japan NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 399 japan hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 400 japan NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 401 australia NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 402 australia Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 403 australia External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 404 australia Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 405 australia Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 406 australia NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 407 australia NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 408 australia NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 409 australia NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 410 australia Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 411 australia portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 412 australia NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 413 australia NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 414 australia NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 415 australia SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 416 australia Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 417 australia Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 418 australia NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 419 australia hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 420 australia NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 421 india NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 422 india Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 423 india External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 424 india Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 425 india Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 426 india NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 427 india NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 428 india NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 429 india NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 430 india Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 431 india portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 432 india NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 433 india NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 434 india NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 435 india SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 436 india Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 437 india Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 438 india NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 439 india hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 440 india NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 441 south korea NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 442 south korea Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 443 south korea External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 444 south korea Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 445 south korea Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 446 south korea NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 447 south korea NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 448 south korea NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 449 south korea NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 450 south korea Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 451 south korea portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 452 south korea NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 453 south korea NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 454 south korea NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 455 south korea SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 456 south korea Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 457 south korea Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 458 south korea NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 459 south korea hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 460 south korea NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 461 singapore NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 462 singapore Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 463 singapore External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 464 singapore Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 465 singapore Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 466 singapore NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 467 singapore NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 468 singapore NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 469 singapore NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 470 singapore Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 471 singapore portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 472 singapore NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 473 singapore NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 474 singapore NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 475 singapore SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 476 singapore Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 477 singapore Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 478 singapore NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 479 singapore hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 480 singapore NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 481 malaysia NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 482 malaysia Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 483 malaysia External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 484 malaysia Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 485 malaysia Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 486 malaysia NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 487 malaysia NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 488 malaysia NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 489 malaysia NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 490 malaysia Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 491 malaysia portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 492 malaysia NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 493 malaysia NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 494 malaysia NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 495 malaysia SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 496 malaysia Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 497 malaysia Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 498 malaysia NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 499 malaysia hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 500 malaysia NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 501 thailand NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 502 thailand Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 503 thailand External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 504 thailand Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 505 thailand Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 506 thailand NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 507 thailand NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 508 thailand NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 509 thailand NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 510 thailand Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 511 thailand portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 512 thailand NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 513 thailand NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 514 thailand NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 515 thailand SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 516 thailand Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 517 thailand Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 518 thailand NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 519 thailand hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 520 thailand NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 521 indonesia NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 522 indonesia Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 523 indonesia External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 524 indonesia Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 525 indonesia Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 526 indonesia NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 527 indonesia NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 528 indonesia NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 529 indonesia NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 530 indonesia Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 531 indonesia portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 532 indonesia NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 533 indonesia NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 534 indonesia NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 535 indonesia SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 536 indonesia Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 537 indonesia Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 538 indonesia NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 539 indonesia hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 540 indonesia NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 541 philippines NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 542 philippines Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 543 philippines External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 544 philippines Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 545 philippines Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 546 philippines NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 547 philippines NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 548 philippines NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 549 philippines NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 550 philippines Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 551 philippines portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 552 philippines NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 553 philippines NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 554 philippines NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 555 philippines SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 556 philippines Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 557 philippines Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 558 philippines NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 559 philippines hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 560 philippines NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 561 Rest of Asia-Pacific NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 562 Middle East & Africa Neuropathic pain Market, By Region, 2019-2028 (USD Million)
TABLE 563 Middle East And Africa Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 564 Middle East And Africa Spinal Cord Stimulation (SCS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 565 Middle East And Africa External Peripheral Nerve Stimulationin Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 566 Middle East And Africa Deep Brain Stimulators (DBS) in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 567 Middle East And Africa Transcutaneous Electrical Nerve Stimulation (TENS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 568 Middle East And Africa Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)
TABLE 569 Middle East And Africa Neuropathic Pain Device Market, By Procedure, 2019-2028 (USD Million)
TABLE 570 Middle East And Africa Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)
TABLE 571 Middle East And Africa Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 572 Middle East And Africa Stationary in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 573 Middle East And Africa Portable in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 574 Middle East And Africa Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)
TABLE 575 Middle East And Africa Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 576 Middle East And Africa Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 577 Middle East And Africa Spinal Stenosis in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 578 Middle East And Africa Chemotherapy-Induced Peripheral Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 579 Middle East And Africa Diabetic Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 580 Middle East And Africa Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 581 Middle East And Africa Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 582 Middle East And Africa Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 583 South Africa Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 584 South Africa Spinal Cord Stimulation (SCS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 585 South Africa External Peripheral Nerve Stimulationin Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 586 South Africa Deep Brain Stimulators (DBS) in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 587 South Africa Transcutaneous Electrical Nerve Stimulation (TENS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 588 South Africa Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)
TABLE 589 South Africa Neuropathic Pain Device Market, By Procedure, 2019-2028 (USD Million)
TABLE 590 South Africa Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)
TABLE 591 South Africa Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 592 South Africa Stationary in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 593 South Africa Portable in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 594 South Africa Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)
TABLE 595 South Africa Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 596 South Africa Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 597 South Africa Spinal Stenosis in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 598 South Africa Chemotherapy-Induced Peripheral Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 599 South Africa Diabetic Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 600 South Africa Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 601 South Africa Hospitals in Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 602 South Africa Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 603 Saudi Arabia Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 604 Saudi Arabia Spinal Cord Stimulation (SCS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 605 Saudi Arabia External Peripheral Nerve Stimulationin Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 606 Saudi Arabia Deep Brain Stimulators (DBS) in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 607 Saudi Arabia Transcutaneous Electrical Nerve Stimulation (TENS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 608 Saudi Arabia Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)
TABLE 609 Saudi Arabia Neuropathic Pain Device Market, By Procedure, 2019-2028 (USD Million)
TABLE 610 Saudi Arabia Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)
TABLE 611 Saudi Arabia Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 612 Saudi Arabia Stationary in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 613 Saudi Arabia Portable in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 614 Saudi Arabia Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)
TABLE 615 Saudi Arabia Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 616 Saudi Arabia Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 617 Saudi Arabia Spinal Stenosis in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 618 Saudi Arabia Chemotherapy-Induced Peripheral Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 619 Saudi Arabia Diabetic Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 620 Saudi Arabia Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 621 Saudi Arabia Hospitals in Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 622 Saudi Arabia Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 623 UAE Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 624 UAE Spinal Cord Stimulation (SCS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 625 UAE External Peripheral Nerve Stimulationin Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 626 UAE Deep Brain Stimulators (DBS) in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 627 UAE Transcutaneous Electrical Nerve Stimulation (TENS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 628 UAE Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)
TABLE 629 UAE Neuropathic Pain Device Market, By Procedure, 2019-2028 (USD Million)
TABLE 630 UAE Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)
TABLE 631 UAE Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 632 UAE Stationary in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 633 UAE Portable in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 634 UAE Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)
TABLE 635 UAE Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 636 UAE Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 637 UAE Spinal Stenosis in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 638 UAE Chemotherapy-Induced Peripheral Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 639 UAE Diabetic Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 640 UAE Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 641 UAE Hospitals in Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 642 UAE Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 643 ISRAEL Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 644 ISRAEL Spinal Cord Stimulation (SCS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 645 ISRAEL External Peripheral Nerve Stimulationin Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 646 ISRAEL Deep Brain Stimulators (DBS) in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 647 iSRAEL Transcutaneous Electrical Nerve Stimulation (TENS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 648 ISRAEL Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)
TABLE 649 ISRAEL Neuropathic Pain Device Market, By Procedure, 2019-2028 (USD Million)
TABLE 650 ISRAEL Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)
TABLE 651 ISRAEL Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 652 ISRAEL Stationary in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 653 ISRAEL Portable in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 654 ISRAEL Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)
TABLE 655 ISRAEL Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 656 ISRAEL Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 657 ISRAEL Spinal Stenosis in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 658 ISRAEL Chemotherapy-Induced Peripheral Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 659 ISRAEL Diabetic Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 660 ISRAEL Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 661 ISRAEL Hospitals in Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 662 ISRAEL Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 663 EGYPT Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 664 EGYPT Spinal Cord Stimulation (SCS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 665 EGYPT External Peripheral Nerve Stimulationin Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 666 EGYPT Deep Brain Stimulators (DBS) in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 667 EGYPT Transcutaneous Electrical Nerve Stimulation (TENS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 668 EGYPT Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)
TABLE 669 EGYPT Neuropathic Pain Device Market, By Procedure, 2019-2028 (USD Million)
TABLE 670 EGYPT Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)
TABLE 671 EGYPT Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 672 EGYPT Stationary in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 673 EGYPT Portable in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 674 EGYPT Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)
TABLE 675 EGYPT Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 676 EGYPT Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 677 EGYPT Spinal Stenosis in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 678 EGYPT Chemotherapy-Induced Peripheral Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 679 EGYPT Diabetic Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 680 EGYPT Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 681 EGYPT Hospitals in Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 682 EGYPT Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 683 EGYPT Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 684 SOUTH AMERICA Neuropathic pain Market, By Region, 2019-2028 (USD Million)
TABLE 685 SOUTH AMERICA Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 686 SOUTH AMERICA Spinal Cord Stimulation (SCS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 687 SOUTH AMERICA External Peripheral Nerve Stimulationin Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 688 SOUTH AMERICA Deep Brain Stimulators (DBS) in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 689 SOUTH AMERICA Transcutaneous Electrical Nerve Stimulation (TENS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 690 SOUTH AMERICA Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)
TABLE 691 SOUTH AMERICA Neuropathic Pain Device Market, By Procedure, 2019-2028 (USD Million)
TABLE 692 SOUTH AMERICA Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)
TABLE 693 SOUTH AMERICA Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 694 SOUTH AMERICA Stationary in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 695 SOUTH AMERICA Portable in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 696 SOUTH AMERICA Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)
TABLE 697 SOUTH AMERICA Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 698 SOUTH AMERICA Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 699 SOUTH AMERICA Spinal Stenosis in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 700 SOUTH AMERICA Chemotherapy-Induced Peripheral Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 701 SOUTH AMERICA Diabetic Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 702 SOUTH AMERICA Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 703 SOUTH AMERICA Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 704 SOUTH AMERICA Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 705 BRAZIL Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 706 BRAZIL Spinal Cord Stimulation (SCS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 707 BRAZIL External Peripheral Nerve Stimulationin Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 708 BRAZIL Deep Brain Stimulators (DBS) in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 709 BRAZIL Transcutaneous Electrical Nerve Stimulation (TENS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 710 BRAZIL Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)
TABLE 711 BRAZIL Neuropathic Pain Device Market, By Procedure, 2019-2028 (USD Million)
TABLE 712 BRAZIL Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)
TABLE 713 BRAZIL Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 714 BRAZIL Stationary in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 715 BRAZIL Portable in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 716 BRAZIL Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)
TABLE 717 BRAZIL Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 718 BRAZIL Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 719 BRAZIL Spinal Stenosis in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 720 BRAZIL Chemotherapy-Induced Peripheral Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 721 BRAZIL Diabetic Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 722 BRAZIL Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 723 BRAZIL Hospitals in Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 724 BRAZIL Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 725 argentina Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 726 ARGENTINA Spinal Cord Stimulation (SCS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 727 ARGENTINA External Peripheral Nerve Stimulationin Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 728 ARGENTINA Deep Brain Stimulators (DBS) in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 729 ARGENTINA Transcutaneous Electrical Nerve Stimulation (TENS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 730 ARGENTINA Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)
TABLE 731 ARGENTINA Neuropathic Pain Device Market, By Procedure, 2019-2028 (USD Million)
TABLE 732 ARGENTINA Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)
TABLE 733 ARGENTINA Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 734 ARGENTINA Stationary in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 735 ARGENTINA Portable in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 736 ARGENTINA Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)
TABLE 737 ARGENTINA Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 738 ARGENTINA Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 739 ARGENTINA Spinal Stenosis in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 740 ARGENTINA Chemotherapy-Induced Peripheral Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 741 ARGENTINA Diabetic Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 742 ARGENTINA Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 743 ARGENTINA Hospitals in Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 744 ARGENTINA Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 745 rest of south america Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
图片列表
FIGURE 1 Global NEUROPATHIC PAIN MARKET: SEGMENTATION
FIGURE 2 GLOBAL NEUROPATHIC PAIN MARKET: DATA TRIANGULATION
FIGURE 3 global Neuropathic pain Market: DROC ANALYSIS
FIGURE 4 Global Neuropathic pain market: Global VS REGIONAL MARKET ANALYSIS
FIGURE 5 Global Neuropathic pain Market: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL Neuropathic pain MARKET: MULTIVARIATE MODELLING
FIGURE 7 GLOBAL Neuropathic pain MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 GLOBAL NEUROPATHIC PAIN MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL NEUROPATHIC PAIN MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL Neuropathic pain MARKET: MARKET type COVERAGE GRID
FIGURE 11 Global Neuropathic pain market: SEGMENTATION
FIGURE 12 NORTH AMERICA is expected to DOMINATE THE GLOBAL Neuropathic pain market AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 GROWING PREVALENCE OF CHRONIC PAIN, NEUROPATHIC CONDITION, AND INCREASING CASES OF DIABETIC NEUROPATHY IS DRIVING THE GLOBAL NEUROPATHIC PAIN MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 SPINAL CORD STIMULATION (SCS) DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL NEUROPATHIC PAIN MARKET IN 2021 & 2028
FIGURE 15 north america is the fastest growing market FOR the Neuropathic pain MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL NEUROPATHIC PAIN MARKET
FIGURE 17 ESTIMATED CASES OF PERIPHERAL NEUROPATHY IN AMERICAN POPULATION
FIGURE 18 PREVALENCE OF NEUROPATHIC PAIN IN TYPE 1 AND TYPE 2 DIABETES
FIGURE 19 global Neuropathic pain market: BY type, 2020
FIGURE 20 global Neuropathic pain market: BY type, 2020-2028 (USD Million)
FIGURE 21 global Neuropathic pain market: BY type, CAGR (2020-2028)
FIGURE 22 global Neuropathic pain market: BY type, LIFELINE CURVE
FIGURE 23 global Neuropathic pain market: BY product type, 2020
FIGURE 24 global Neuropathic pain market: BY product type, 2020-2028 (USD Million)
FIGURE 25 global Neuropathic pain market: BY product type, CAGR (2020-2028)
FIGURE 26 global Neuropathic pain market: BY product type, LIFELINE CURVE
FIGURE 27 global Neuropathic pain market: BY procedure, 2020
FIGURE 28 global Neuropathic pain market: BY procedure, 2020-2028 (USD Million)
FIGURE 29 global Neuropathic pain market: BY procedure, CAGR (2020-2028)
FIGURE 30 global Neuropathic pain market: BY procedure, LIFELINE CURVE
FIGURE 31 global Neuropathic pain market: BY technology, 2020
FIGURE 32 global Neuropathic pain market: BY technology, 2020-2028 (USD Million)
FIGURE 33 global Neuropathic pain market: BY technology, CAGR (2020-2028)
FIGURE 34 global Neuropathic pain market: BY technology, LIFELINE CURVE
FIGURE 35 global Neuropathic pain market: BY modality, 2020
FIGURE 36 global Neuropathic pain market: BY modality, 2020-2028 (USD Million)
FIGURE 37 global Neuropathic pain market: BY modality, CAGR (2020-2028)
FIGURE 38 global Neuropathic pain market: BY modality, LIFELINE CURVE
FIGURE 39 global Neuropathic pain market: BY mode of purchase, 2020
FIGURE 40 global Neuropathic pain market: BY mode of purchase, 2020-2028 (USD Million)
FIGURE 41 global Neuropathic pain market: BY mode of purchase, CAGR (2020-2028)
FIGURE 42 global Neuropathic pain market: BY mode of purchase, LIFELINE CURVE
FIGURE 43 global Neuropathic pain market: BY pain type, 2020
FIGURE 44 global Neuropathic pain market: BY pain type, 2020-2028 (USD Million)
FIGURE 45 global Neuropathic pain market: BY pain type, CAGR (2020-2028)
FIGURE 46 global Neuropathic pain market: BY pain type, LIFELINE CURVE
FIGURE 47 global Neuropathic pain market: BY indication, 2020
FIGURE 48 global Neuropathic pain market: BY indication, 2020-2028 (USD Million)
FIGURE 49 global Neuropathic pain market: BY indication, CAGR (2020-2028)
FIGURE 50 global Neuropathic pain market: BY indication, LIFELINE CURVE
FIGURE 51 global Neuropathic pain market: BY end user, 2020
FIGURE 52 global Neuropathic pain market: BY end user, 2020-2028 (USD Million)
FIGURE 53 global Neuropathic pain market: BY end user, CAGR (2020-2028)
FIGURE 54 global Neuropathic pain market: BY end user, LIFELINE CURVE
FIGURE 55 global Neuropathic pain market: BY distribution channel, 2020
FIGURE 56 global Neuropathic pain market: BY distribution channel, 2020-2028 (USD Million)
FIGURE 57 global Neuropathic pain market: BY distribution channel, CAGR (2020-2028)
FIGURE 58 global Neuropathic pain market: BY distribution channel, LIFELINE CURVE
FIGURE 59 GLOBAL neuropathic Pain market: SNAPSHOT (2020)
FIGURE 60 GLOBAL neuropathic Pain market: BY COUNTRY (2020)
FIGURE 61 GLOBAL neuropathic Pain market: BY COUNTRY (2021 & 2028)
FIGURE 62 GLOBAL neuropathic Pain market: BY COUNTRY (2020 & 2028)
FIGURE 63 GLOBAL neuropathic Pain market: BY Product & services (2021-2028)
FIGURE 64 North-america Neuropathic Pain MARKET: SNAPSHOT (2020)
FIGURE 65 North-america Neuropathic Pain MARKET: BY COUNTRY (2020)
FIGURE 66 North-america Neuropathic Pain MARKET: BY COUNTRY (2021 & 2028)
FIGURE 67 North-america Neuropathic Pain MARKET: BY COUNTRY (2020 & 2028)
FIGURE 68 North-america Neuropathic Pain MARKET: BY product & Services (2021-2028)
FIGURE 69 Europe Neuropathic Pain MARKET: SNAPSHOT (2020)
FIGURE 70 Europe Neuropathic Pain MARKET: BY COUNTRY (2020)
FIGURE 71 Europe Neuropathic Pain MARKET: BY COUNTRY (2021 & 2028)
FIGURE 72 Europe Neuropathic Pain MARKET: BY COUNTRY (2020 & 2028)
FIGURE 73 Europe Neuropathic Pain MARKET: BY product & Services (2021-2028)
FIGURE 74 Asia-Pacific Neuropathic Pain MARKET: SNAPSHOT (2020)
FIGURE 75 Asia-Pacific Neuropathic Pain MARKET: BY COUNTRY (2020)
FIGURE 76 Asia-Pacific Neuropathic Pain MARKET: BY COUNTRY (2021 & 2028)
FIGURE 77 Asia-Pacific Neuropathic Pain MARKET: BY COUNTRY (2020 & 2028)
FIGURE 78 Asia-Pacific Neuropathic Pain MARKET: BY product & Services (2021-2028)
FIGURE 79 Middle East & Africa NEUROPATHIC PAIN market: SNAPSHOT (2020)
FIGURE 80 Middle East & Africa NEUROPATHIC PAIN market: BY COUNTRY (2020)
FIGURE 81 Middle East & Africa NEUROPATHIC PAIN market: BY COUNTRY (2021 & 2028)
FIGURE 82 Middle East & Africa NEUROPATHIC PAIN market: BY COUNTRY (2020 & 2028)
FIGURE 83 Middle East & Africa NEUROPATHIC PAIN market: BY type (2021-2028)
FIGURE 84 SOUTH AMERICA NEUROPATHIC PAIN market: SNAPSHOT (2020)
FIGURE 85 SOUTH AMERICA NEUROPATHIC PAIN market: BY COUNTRY (2020)
FIGURE 86 SOUTH AMERICA NEUROPATHIC PAIN market: BY COUNTRY (2021 & 2028)
FIGURE 87 SOUTH AMERICA NEUROPATHIC PAIN market: BY COUNTRY (2020 & 2028)
FIGURE 88 SOUTH AMERICA NEUROPATHIC PAIN market: BY type (2021-2028)
FIGURE 89 Global Neuropathic Pain market: company share 2020 (%)
FIGURE 90 North America Neuropathic Pain Market: company share 2020 (%)
FIGURE 91 EUROPE Neuropathic Pain Market: company share 2020 (%)
FIGURE 92 ASIA-PACIFIC Neuropathic Pain Market: company share 2020 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
